US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LMP Capital and Income Fund Inc

15.76

+0.01000.06%

Post-market: 15.760.00000.00%16:04 EDT

Volume:114.27K

Turnover:1.80M

Market Cap:270.67M

PE:3.10

High:15.80

Open:15.73

Low:15.63

Close:15.75

Loading ...

Overview Company News Filings

Press Release: BioLineRx Reports 2024 Financial Results and Provides Corporate Update

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires

Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

Beam Therapeutics: Anticipated Growth Driven by BEAM-302 and SCD Franchise Progress

OpCo reiterates Outperform on Fulcrum given bullish vibes ahead of SCD readout

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024

Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes

Press Release: Franklin Templeton Fund Adviser, LLC Announces Distributions for Certain Closed End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2025

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

2 Biotech Stocks to Buy Hand Over Fist in February

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SCD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCD\",,,,,undefined,":{"symbol":"SCD","market":"US","secType":"STK","nameCN":"LMP Capital and Income Fund Inc","latestPrice":15.76,"timestamp":1752004800000,"preClose":15.75,"halted":0,"volume":114270,"hourTrading":{"tag":"盘后","latestPrice":15.76,"preClose":15.76,"latestTime":"16:04 EDT","volume":2,"amount":31.52,"timestamp":1752005055560},"delay":0,"floatShares":0,"shares":17174598,"eps":5.087105,"marketStatus":"Post-Mkt","change":0.01,"latestTime":"07-08 19:18:37 EDT","open":15.73,"high":15.8,"low":15.63,"amount":1795072.991067,"amplitude":0.010794,"askPrice":18.48,"askSize":100,"bidPrice":15.09,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":5.087105,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1752019200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":15.75,"dividendRate":0.087563,"postHourTrading":{"tag":"盘后","latestPrice":15.76,"preClose":15.76,"latestTime":"16:04 EDT","volume":2,"amount":31.52,"timestamp":1752005055560},"volumeRatio":1.113806},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCD\",,,,,undefined,":{"symbol":"SCD","floatShares":0,"roa":"1.31%","roe":"30.34%","lyrEps":5.087105,"volumeRatio":1.113806,"shares":17174598,"dividePrice":1.38,"high":15.8,"amplitude":0.010794,"preClose":15.75,"low":15.63,"week52Low":13.35,"pbRate":"0.85","psRate":"24.64","week52High":17.96,"institutionHeld":0.2296,"latestPrice":15.76,"committee":0.960784,"eps":5.087105,"divideRate":0.087563,"volume":114270,"delay":0,"ttmEps":5.087105,"open":15.73,"prevYearClose":17.2,"prevWeekClose":15.97,"prevMonthClose":15.6,"prevQuarterClose":15.6,"fiveDayClose":15.6,"twentyDayClose":16.57,"sixtyDayClose":14.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523917611","title":"Press Release: BioLineRx Reports 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917611","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917611?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"- Reports meaningful progress in the evaluation of assets for potential in-licensing and development in the areas of oncology and rare diseases -. - Executed license agreement with Ayrmid Pharma Ltd. for APHEXDA  with $10 million upfront payment, up to $87 million in commercial milestones, and high double-digit royalties on net sales -. - Completed financings raising combined gross proceeds of $19 million and reduced operating expense run rate by 70%, extending the Company's cash runway through H2 2026 -. - Management to host conference call today, March 31 , at 8:30 am EDT -. TEL AVIV, Israel, March 31, 2025 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December 31, 2024, and provided a corporate update.tumors, and across all territories except Asia- Licen","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IP","BK4585","LU1481599808.USD","LU2463526074.USD","SCD","BK4109","R","IE00B3T34201.USD","BK4232","BK4022","BLRX","ASH","BK4588","LU1481600234.SGD","BK4136","BK4139","LU1487256676.USD"],"gpt_icon":0},{"id":"2522504802","title":"Promising Genomics & Synthetic Biology Stocks to Consider in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522504802","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522504802?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:39","pubTimestamp":1743169140,"startTime":"0","endTime":"0","summary":"Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary focus is on characterizing all the genes of an organism, rather than individual genes.The evolution of genomics in the last couple of decades to decode diseases has ushered in a revolutionary era in genetic medicine. There have been several breakthroughs in this field, attracting the attention of pharma and biotech companies. Of late, genomic information is being used to evaluate individual responses to drugs and facilitate the development of targeted therapies.Interestingly, genomics has paved the way for innovative concepts like synthetic biology, which applies engineering principles to biology. Synthetic biology products serve life sciences researchers across a variety of healthcare applications, including drug discovery, disease detection, enzyme engineering, gene editing and basic ac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/promising-genomics-synthetic-biology-stocks-133900631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234572021.USD","ILMN","BK4581","SG9999001440.SGD","LU1674673691.USD","LU0820561818.USD","BK4585","LU2756315318.SGD","RNA","BEAM","LU1496350171.SGD","SCD","LU0868494617.USD","IE00BWXC8680.SGD","LU0823411888.USD","LU1162221912.USD","LU1914381329.SGD","IE00BKVL7J92.USD","BK4533","BK4548","BK4566","LU0354030511.USD","LU0942090050.USD","BK4535","TWST","LU1496350502.SGD","LU0820562030.AUD","HD","LU1035775433.USD","BK4504","LU0689472784.USD","LU1861559042.SGD","WVE","LU2756315664.SGD","LU1674673428.USD","LU1929549753.HKD","NGS","IE00B1XK9C88.USD","LU1989772840.SGD","LU1551013425.SGD","CRSP","LU0320765646.SGD","NTLA","LU0943347566.SGD","LU1861558580.USD","BK4179","BK4556","LU0079474960.USD","LU0868494708.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2522839685","title":"Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2522839685","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522839685?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:40","pubTimestamp":1742938846,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where CRISPR Therapeutics AG stands against other biotech stocks.Biotech Sector Set for Growth Amid Innovation and Investor Interest. The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention. The industry has recovered from a challenging 2024 and is poised for significant expansion led by advances in personalized medicine, AI-driven drug discovery, and growing demand for biologics. MarketsandMarkets predicted that the global biotech market would expand by a strong 13%, from $483.0 billion in 2024 to $546.0 billion in 2025. This expansion demonstrates the sector’s tenacity and promise for growth.For this article, we shortlisted stocks that met the following criteria: a market capitalization of over $2 billion, cove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-promising-214046771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4210","BK4556","NQmain","QLD",".IXIC","LU1861559042.SGD","MNQmain","CRSP","PSQ","BK4585","SCD","TQQQ","QID","USAW.SI","USJW.SI","LU1861558580.USD","BK4611","SQQQ","BK4588","NVIW.SI","BK4139","AG","TSYW.SI"],"gpt_icon":1},{"id":"2522085246","title":"SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522085246","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522085246?lang=en_us&edition=fundamental","pubTime":"2025-03-25 05:30","pubTimestamp":1742851800,"startTime":"0","endTime":"0","summary":"DENVER, March 24, 2025  -- SeaStar Medical Holding Corporation , a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its fourth quarter and year-end 2024 financial results after market close on Thursday, March 27, 2025, and host a webcast and conference call to discuss its financial results and business progress.Thursday, March 27, at 4:30 p.m. ET / 1:30 p.m. PT. The live webcast and replay can be foundhere.A replay of the call will be available after 7:30 pm ET and can be accessed as follows:. The call replay number is 1  800-9909 and will be available through April 3, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/seastar-medical-report-fourth-quarter-213000963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICUCW","SCD","ICU","BK4082"],"gpt_icon":0},{"id":"2520151435","title":"CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520151435","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520151435?lang=en_us&edition=fundamental","pubTime":"2025-03-19 22:27","pubTimestamp":1742394420,"startTime":"0","endTime":"0","summary":"Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52.This decline in CRSP stock is mainly due to a lack of pipeline updates, which is not sitting well with investors. Also, the company is yet to record revenues from the sales of its sole-marketed product Casgevy, despite it being approved in early 2024.Shares of CRISPR Therapeutics have plunged 43% in the past year compared with the industry’s 7% decline, as seen in the chart below. The stock has also underperformed the sector and the S&P 500 index. Shares of the company are currently trading below their 50-day and 200-day moving averages.CRSP Stock Underperforms Industry, Sector & S&P 500. CRSP is also exploring the potential of these next-generation candidates in other indications. Last year, it started two new clinical studies — one evaluating CTX131 for hematological malignancies  and another assessing CTX112 in systemic lupus erythematosus indication, systemic sclerosis and inflammat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crispr-therapeutics-stock-trades-near-142700105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823416689.USD","IE00BZ9MQY76.HKD","LENZ","IE00B2B36J28.USD","CRSP","BK4505","LU2362541513.USD","LU1430594728.SGD","LU0079474960.USD","LU0109394709.USD","LU0417517546.SGD","LU2362541273.HKD","IE0002141913.USD","IE00B19Z9P08.USD","IE0002270589.USD","BK4023","BK4567","LU0757428866.USD","LU1069344957.HKD","BK4585","BK4588","IE00BFTCPJ56.SGD","LU1093756325.SGD","BK4611","LU0256863811.USD","LU2456880835.USD","BK4556","IE00B4R5TH58.HKD","LU0566484027.USD","VERX","LU2417539215.USD","BEAM","IE00B19Z3581.USD","LU1585245621.USD","LU2462157665.USD","LU0234570918.USD","BK4535","LU0289739699.SGD","SCD","NTLA","LU2236285917.USD","LU2324357040.USD","BK4139","LU1815336091.USD","IE00B19Z9Z06.USD","VRTX","IE00BJT1NW94.SGD","LU1559883803.SGD","IE0009355771.USD","BK4532"],"gpt_icon":0},{"id":"2520671537","title":"NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award","url":"https://stock-news.laohu8.com/highlight/detail?id=2520671537","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520671537?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:45","pubTimestamp":1742301900,"startTime":"0","endTime":"0","summary":"Company recognized for treatment recently approved in the U.S. for pediatric acute kidney injury  due to sepsis.NEW YORK, March 18, 2025 /PRNewswire/ -- SeaStar Medical  has been selected to receive the 2025 Corporate Innovator Award from theNational Kidney Foundation at the 2025 Spring Clinical Meetings in Boston.In February 2024, SeaStar Medical's QUELIMMUNE Selective Cytopheretic Device for Pediatrics  received FDA approval as the first and only therapeutic device for the treatment of pediatric Acute Kidney Injury due to sepsis.\"AKI has devastatingly highly rates of morbidity and mortality, especially in children\" said Kevin Longino, CEO, National Kidney Foundation and a kidney transplant recipient. \"This Corporate Innovator Award recognizes SeaStar Medical's significant contribution to improving the lives of pediatric patients with AKI and we congratulate them on this achievement.\". NKF Spring Clinical MeetingsFor more than 30 years, nephrology healthcare professionals from across ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nkf-honors-seastar-medical-2025-124500762.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nkf-honors-seastar-medical-2025-124500762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","KRT","ICUCW","BK4104","ICU","SCD","BK4539"],"gpt_icon":0},{"id":"2520643131","title":"Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires","url":"https://stock-news.laohu8.com/highlight/detail?id=2520643131","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520643131?lang=en_us&edition=fundamental","pubTime":"2025-03-18 17:26","pubTimestamp":1742289975,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated  stands against other best biotech stocks.Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the industry’s companies could see significant growth in the months to come. Senior partner and principal of investments at Novo Holdings, Johan Hueffer, spoke on CNBC on November 28 about his macro outlook for life sciences investments. He claimed that in the past few years, biotechs have had trouble raising funding. Over the past quarter or two, though, that tendency has begun to improve.Flood’s report also emphasized how the biotech sector has recently demonstrated better fundamentals, which have been ascribed to superior clinical outcomes and a more favorable regulatory environment. Goldman’s data shows that hedge funds continue to underinvest in biotechnology despite these ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-one-best-092615738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4552","PSQ","BK4585","IE0004091025.USD","US6M.BOND","NQmain","TQQQ","IE00BFXG1179.USD","BK4533","QID","USJW.SI","VERX","IE00BSNM7G36.USD","LU2750360997.AUD","US30Y.BOND","LU2471134796.USD","LU0058720904.USD","LU2324357040.USD","US7Y.BOND","FOMC","BK4504","BK4588","LU2237443978.SGD","US3Y.BOND",".IXIC","QLD","US5Y.BOND","MNQmain","LU2237443465.HKD","LU1791807156.HKD","LU2471134879.HKD","TSYW.SI","BK4093","LU2462157665.USD","SCD","LU2237443549.SGD","US12M.BOND","USAW.SI","CF","BK4567","US2Y.BOND","LU0417517546.SGD","LU0096364046.USD","NVIW.SI","SQQQ","LU2237443382.USD","VRTX","IE00BJJMRZ35.SGD","US10Y.BOND"],"gpt_icon":1},{"id":"2520499572","title":"Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520499572","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520499572?lang=en_us&edition=fundamental","pubTime":"2025-03-17 22:47","pubTimestamp":1742222820,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Incorporated VRTX stock has plunged 25.3% this year so far against the industry’s 5.4% increase.The stock’s price increase is mainly because the company gained approval for two new products, its novel non-opioid pain medicine Journavx  and its fifth cystic franchise  medicine Alyftrek, recently. Let us understand the company’s strengths and weaknesses to better analyze how to play the stock given the recent increase in price.Vertex holds a dominant position in the cystic franchise  market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product revenues rose in the double-digit range for 10 consecutive years.Journavx , Vertex’s non-opioid NaV1.8 pain signal inhibitor, for the treatment of moderate-to-severe acute pain, was approved by the FDA in January 2025. At the fourth-qu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-25-ytd-buy-sell-144700220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2362541513.USD","LU0823416689.USD","LU2417539215.USD","LU0289739699.SGD","LU1585245621.USD","LU0566484027.USD","LU2362541273.HKD","BK4551","SCD","LU2324357040.USD","LU2362540622.SGD","IE00B19Z9P08.USD","VERX","LU0061475181.USD","LU0079474960.USD","LU2236285917.USD","BK4567","IE00B19Z3581.USD","LU2462157665.USD","LU0320765992.SGD","IE00BZ9MQY76.HKD","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU1069344957.HKD","BK4548","BK4532","BK4534","BK4023","LU1035775433.USD","LU0058720904.USD","LU2237438978.USD","BK4093","BK4138","BK4568","LU0757428866.USD","BK4556","IE00B4R5TH58.HKD","BK4501","LU2456880835.USD","CRSP","BK4611","VTNR","IE0009355771.USD","LU1861559042.SGD","VRTX","IE00B19Z3B42.SGD","LU1430594728.SGD","IE00B2B36J28.USD","CF"],"gpt_icon":1},{"id":"2517896069","title":"Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2517896069","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517896069?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:05","pubTimestamp":1741122300,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., March  04, 2025  (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to im","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036953/0/en/Fulcrum-Therapeutics-to-Participate-in-the-Leerink-Partners-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4137","FULC","SCD","HCSG"],"gpt_icon":0},{"id":"2514718831","title":"Beam Therapeutics: Anticipated Growth Driven by BEAM-302 and SCD Franchise Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2514718831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514718831?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:18","pubTimestamp":1740572308,"startTime":"0","endTime":"0","summary":"BMO Capital analyst Kostas Biliouris has maintained their bullish stance on BEAM stock, giving a Buy rating yesterday. Kostas Biliouris’s rating is...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/beam-therapeutics-anticipated-growth-driven-by-beam-302-and-scd-franchise-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/beam-therapeutics-anticipated-growth-driven-by-beam-302-and-scd-franchise-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4585","BK4556","BK4588","BK4097","PRGS","BK4139","SCD","BK4535","BK4505","BEAM"],"gpt_icon":0},{"id":"2514804394","title":"OpCo reiterates Outperform on Fulcrum given bullish vibes ahead of SCD readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514804394?lang=en_us&edition=fundamental","pubTime":"2025-02-26 03:06","pubTimestamp":1740510391,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Matthew Biegler met with Fulcrum Therapeutics (FULC)’ management Tuesday after the company reported year-end financials. The la...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opco-reiterates-outperform-on-fulcrum-given-bullish-vibes-ahead-of-scd-readout?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opco-reiterates-outperform-on-fulcrum-given-bullish-vibes-ahead-of-scd-readout?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCD"],"gpt_icon":0},{"id":"2514409843","title":"Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2514409843","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514409843?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:00","pubTimestamp":1740484800,"startTime":"0","endTime":"0","summary":"― On track to provide clinical data from the 12 mg dose cohort from the Phase 1b PIONEER trial of pociredir in SCD in mid-2025 and the 20 mg dose cohort by the end of 2025 ―。― Ended 2024 with $241.0 million in cash, cash equivalents, and marketable securities; cash runway into at least 2027 ―。― Conference call and webcast scheduled for 8:00 a.m. ET today ―。CAMBRIDGE, Mass., Feb. 25, 2025  -- Fulcrum Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today reported financial results for the fourth quarter and full year of 2024 as well as a business update.Fulcrum continues to advance its program for the potential treatment of inherited aplastic anemias, such as Diamond-Blackfan anemia , Shwachman-Diamond syndrome, and Fanconi anemia, and plans to submit an IND for DBA during the fourth quarter of 2025.Collaboration Revenue: There was no collaboration revenue for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fulcrum-therapeutics-announces-recent-business-120000018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DBA","BK4007","FULC","SCD"],"gpt_icon":0},{"id":"2514093342","title":"Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2514093342","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514093342?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:00","pubTimestamp":1740484800,"startTime":"0","endTime":"0","summary":"Enrollment Target for Adult Sickle Cell Disease Patients Achieved in BEACON Trial ofBEAM-101; Dosing of 30 Patients and Updated Data Expected by Mid-2025 Initial Data from Phase 1/2 Trial of BEAM-302 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/25/3031842/0/en/Beam-Therapeutics-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results-and-Reiterates-Anticipated-Catalysts.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","BK4139","ASH","BK4588","LU2463526074.USD","LENZ","BK4556","BK4535","BK4505","SCD","BEAM","BK4585"],"gpt_icon":0},{"id":"2513720437","title":"2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720437","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513720437?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:00","pubTimestamp":1740405600,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics and Intellia Therapeutics are both unprofitable gene-editing companies.Biotech companies can skyrocket in a short period because of excellent clinical or regulatory progress. And if we take the word of Wall Street analysts, some of them will do precisely that in the next year.Take CRISPR Therapeutics  and Intellia Therapeutics , two biotechs specializing in gene editing. The former's average price target, according to Yahoo!Finance, is $83.60; the latter earns a price target of $50.80 from analysts. That implies an upside of about 66% for CRISPR Therapeutics and 415% for Intellia Therapeutics.These two companies have significantly lagged the market over the past three years. Could they turn around and live up to Wall Street's expectations?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/24/2-beaten-down-stocks-to-buy-before-they-soar-by-66/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["CRSP","LU1861559042.SGD","BK4585","LU1861558580.USD","BK4556","SCD","BK4588","BK4139"],"gpt_icon":1},{"id":"2513754757","title":"CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2513754757","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513754757?lang=en_us&edition=fundamental","pubTime":"2025-02-24 02:34","pubTimestamp":1740335664,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to take a look at where CRISPR Therapeutics AG  stands against the other oversold pharma stocks to buy according to analysts.On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity drugs. She believed the industry may not underperform this year, at least in the first half. However, there are still several questions surrounding the performance of obesity drugs, as major players in the domain have exhibited contrasting previous year performance.Angelica Peebles, CNBC’s Health and Pharma reporter, sat with Eli Lilly’s Chief Scientific Officer to talk about the weight loss sector. From the conversation, she reported that the domain poses opportunity for drugs that are easier to use, such as pills, and medicines that make peop","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-most-183424796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","USAW.SI",".IXIC","BK4588","LU1861559042.SGD","PSQ","BK4210","BK4585","SCD","LU1861558580.USD","QID","BK4139","NQmain","QLD","USJW.SI","MNQmain","TSYW.SI","NVIW.SI","CRSP","AG","BK4556","TQQQ"],"gpt_icon":1},{"id":"2513213797","title":"Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes","url":"https://stock-news.laohu8.com/highlight/detail?id=2513213797","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513213797?lang=en_us&edition=fundamental","pubTime":"2025-02-22 01:35","pubTimestamp":1740159346,"startTime":"0","endTime":"0","summary":"According to multiple media reports on Thursday, PfizerInc.  has terminated the global development and commercialization of its hemophilia B gene therapy, Beqvez.Also Read: uniQure/ CSL Behring’s Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years. In a statement toNikkei Asia, Pfizer said the decision was due to \"the limited interest patients and their doctors have demonstrated in hemophilia gene therapies.”The U.S. drugmaker said it would focus on different treatment for the disorder, citing low interest.In December 2024, Pfizer walked awayfrom its hemophilia A co-development pact with Sangamo Therapeutics Inc  giroctocogene fitelparvovec, an investigational gene therapy product candidate.According to a Reuters report, Pfizer will continue to invest resources in Hympavzi , which is approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients with hemophilia A or hemophilia B.Hympavzi is the first and o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-discontinues-hemophilia-gene-therapy-173546804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","LU1066053197.SGD","SG9999001176.USD","SG9999011175.SGD","SGMO","BK4007","IE00B19Z3581.USD","IE00BLSP4239.USD","BK4581","IE00BZ1G4Q59.USD","BK4534","IE00BLSP4452.SGD","IE000M9KFDE8.USD","SCD","BK4550","LU1057294990.SGD","IE00B19Z3B42.SGD","NVO","SG9999013999.USD","LU0122379950.USD","LU0306807586.USD","BK4533","SG9999002224.SGD","IE00BBT3K403.USD","PFE","SG9999001176.SGD","BK4568","LU0170899867.USD","BK4556","LU1023059063.AUD","LU1066051498.USD","LU0225771236.USD","LU0234572021.USD","LU1894683348.USD","LU0225284248.USD","IE0002270589.USD","LU0058720904.USD","BK4588","IE00BKVL7J92.USD","LU0456855351.SGD","BK4585","LU0868494617.USD","LU0321505868.SGD","SG9999003800.SGD","LU0154236417.USD","BK4592","LU1093756168.USD","LU1883839398.USD","LU0985481810.HKD","LU0321505439.SGD"],"gpt_icon":1},{"id":"2512510129","title":"Press Release: Franklin Templeton Fund Adviser, LLC Announces Distributions for Certain Closed End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512510129","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512510129?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"Franklin Templeton Fund Adviser, LLC Announces Distributions for Certain Closed End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2025. The following dates apply to the distribution schedule below:.  Please see table below for each Fund's estimated source of distributions.Under the terms of each Fund's managed distribution policy, each Fund seeks to maintain a consistent distribution level derived from the income and capital gains generated from the Fund's investment portfolio. To the extent that sufficient distributable income is not available on a monthly basis, each Fund will distribute long-term capital gains and/or return of capital in order to maintain its managed distribution rate. A return of capital may occur, for example, when some or all of the money that was invested in the Fund is paid back to shareholders. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMD","BK4161","LU2229751404.USD","FELE","LU2089279066.USD","SCD","BWG"],"gpt_icon":0},{"id":"2512161435","title":"CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512161435","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512161435?lang=en_us&edition=fundamental","pubTime":"2025-02-18 22:13","pubTimestamp":1739887980,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics CRSP stock rose more than 25% in the past week, thanks to the encouraging fourth-quarter 2024 results and a rating upgrade by a Wall Street analyst.Though CRSP’s quarterly earnings and sales declined year over year, they significantly beat estimates. In the year-ago period, CRISPR Therapeutics received a major milestone payment from partner Vertex Pharmaceuticals VRTX in connection with the approval of one-shot gene therapy Casgevy for two blood disorders.Alongside earnings results, management also cited pipeline advancements and updates on nearly all its pipeline candidates expected throughout this year. Based on the positive expectations for the company’s clinical programs, an analyst at Evercore ISI upgraded CRSP’s rating from \"In Line\" to \"Outperform\" while also significantly raising the target price by 65% to $99.In December 2024, CRSP presented positive preliminary results from the CTX112 study at a major medical meeting. These results showed strong efficacy c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crsp-stock-rises-25-week-141300851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756325.SGD","LU2237438978.USD","IE0002270589.USD","LU1559883803.SGD","LU0823416689.USD","BK4532","IE00B19Z9P08.USD","LU0079474960.USD","IE00BFTCPJ56.SGD","VERX","BK4533","IE00B19Z9Z06.USD","LU2462157665.USD","CRSP","LU0889565916.HKD","LU1430594728.SGD","LU0417517546.SGD","LU1861558580.USD","LU2362540622.SGD","LU1093756168.USD","LU0058720904.USD","LU0566484027.USD","BK4505","VRTX","LU0256863811.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1035775433.USD","LU2236285917.USD","LU2417539215.USD","IE00BJJMRZ35.SGD","BK4585","IE00B19Z3B42.SGD","BK4023","BK4139","LU0109394709.USD","NTLA","SCD","IE00B894F039.SGD","LU2362541513.USD","LU0234570918.USD","BK4588","LU1815336091.USD","BEAM","LU0061475181.USD","LU1585245621.USD","BK4567","LU0757428866.USD","BK4535","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2510504858","title":"Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2510504858","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510504858?lang=en_us&edition=fundamental","pubTime":"2025-02-10 18:15","pubTimestamp":1739182500,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics is a leader in gene editing and could make important breakthroughs.Amgen has a strong lineup of products, a deep pipeline, and a strong dividend program.Regeneron should perform well despite challenges to one of its growth drivers.Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader equities.While it can be hard to separate the wheat from the chaff, let's consider three companies, all in the biotech industry, that were market losers last year but could recover given enough time: CRISPR Therapeutics , Amgen , and Regeneron .If you have $1,000 to spare (don't dip into money earmarked for important things or a rainy day!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/10/investing-1000-in-these-3-beaten-down-stocks-could/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4504","IE00BKVL7J92.USD","LU1035775433.USD","LU0823434583.USD","BK4550","LU1551013425.SGD","BK4556","IE00BWXC8680.SGD","LU0820561818.USD","LU1496350171.SGD","LU0354030511.USD","BK4533","LU1551013342.USD","BK4567","LU0820562030.AUD","LU1674673691.USD","LU1929549753.HKD","BK4581","LU0868494708.USD","LU1861559042.SGD","LU2756315664.SGD","LU0320765646.SGD","BK4566","CRSP","LU1989772840.SGD","BK4585","SCD","HD","LU1861558580.USD","IE00B1XK9C88.USD","IE00BSNM7G36.USD","BK4083","LU0823434740.USD","LU0823411888.USD","LU1162221912.USD","LU0354030438.USD","LU0943347566.SGD","LU0820561909.HKD","BK4588","BK4534","LU0689472784.USD","BK4139","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU1069344957.HKD","LU1496350502.SGD","LU0868494617.USD","LU0942090050.USD","LU0234572021.USD"],"gpt_icon":1},{"id":"2510408700","title":"2 Biotech Stocks to Buy Hand Over Fist in February","url":"https://stock-news.laohu8.com/highlight/detail?id=2510408700","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510408700?lang=en_us&edition=fundamental","pubTime":"2025-02-09 23:15","pubTimestamp":1739114100,"startTime":"0","endTime":"0","summary":"Vertex has successfully diversified its already strong lineup of medicines.Moderna's drug pipeline should lead to more significant breakthroughs.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/09/2-biotech-stocks-to-buy-hand-over-fist-in-february/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["VRTX","LU0266013472.USD","LU0823416689.USD","LU1929549753.HKD","SG9999015358.SGD","LU0985320562.USD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU1037948897.HKD","LU1069347547.HKD","SG9999001176.USD","VERX","IE00BJJMRZ35.SGD","LU0320765646.SGD","LU2461242641.AUD","LU2023250843.SGD","LU2362541273.HKD","LU1061106388.HKD","LU0211331839.USD","LU0320765992.SGD","LU2468319806.SGD","LU1934455194.USD","IE0002141913.USD","BK4533","LU2089984988.USD","SG9999014542.SGD","IE00BLSP4452.SGD","IE00B894F039.SGD","LU1989772923.USD","LU1585245621.USD","SG9999002224.SGD","LU0256863811.USD","LU0234570918.USD","LU0965508806.USD","LU2023250504.SGD","LU0070302665.USD","BK4093","LU2361045086.USD","CF","LU0289739699.SGD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU1035773651.USD","LU0965509101.SGD","MRK","LU0861579265.USD","SCD","LU1291159041.SGD","LU0889565916.HKD","IE00BJT1NW94.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCD\",params:#limit:5,,,undefined,":[{"date":"2025-08-22","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-22","defaultRemindTime":1755869400000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-02","payableDate":"2025-08-22","currency":"USD","dateTimestamp":1755835200000,"payDate":"2025-09-02"},{"date":"2025-06-23","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-07-01"},{"market":"US","date":"2025-06-12","symbol":"SCD","firstDealingDate":"2025-06-12","lastDealingDate":"2025-07-11","announcementDate":"2025-06-02","defaultRemindTime":1749735000000,"recordDate":"2025-06-12","rightsSymbol":"SCD.RTWI","type":"rights","dateTimestamp":1749700800000},{"date":"2025-05-22","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-22","defaultRemindTime":1747920600000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-02","payableDate":"2025-05-22","currency":"USD","dateTimestamp":1747886400000,"payDate":"2025-06-02"},{"date":"2025-04-23","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-23","defaultRemindTime":1745415000000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-23","currency":"USD","dateTimestamp":1745380800000,"payDate":"2025-05-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCD\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-16","recordDate":"2015-09-18","paymentDate":"2015-09-25","value":0.28,"currency":"USD"},{"executeDate":"2015-12-16","recordDate":"2015-12-18","paymentDate":"2015-12-24","value":0.31,"currency":"USD"},{"executeDate":"2016-03-16","recordDate":"2016-03-18","paymentDate":"2016-03-24","value":0.31,"currency":"USD"},{"executeDate":"2016-06-15","recordDate":"2016-06-17","paymentDate":"2016-06-24","value":0.31,"currency":"USD"},{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.31,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCD","date":"2025-07-07","current":3.145051,"percent":0.760691,"low":-75.230419,"twenty":-11.623592,"median":2.603727,"eighty":3.846088,"high":10.684334,"avg":-8.332201,"sd":21.995243,"marketCap":274278330},"quantilePoints":[{"date":"2020-07-10","current":3.839938,"twenty":2.516908,"median":10.990385,"eighty":89.994993,"marketCap":179653466},{"date":"2020-07-17","current":3.920658,"twenty":2.516908,"median":10.990385,"eighty":89.994993,"marketCap":183429966},{"date":"2020-07-24","current":3.897595,"twenty":2.516908,"median":10.990385,"eighty":89.994993,"marketCap":182350966},{"date":"2020-07-31","current":-9.700105,"twenty":-3.511994,"median":10.946787,"eighty":89.994993,"marketCap":183429966},{"date":"2020-08-07","current":-9.985402,"twenty":-3.719344,"median":10.880056,"eighty":89.994993,"marketCap":188824965},{"date":"2020-08-14","current":-10.270699,"twenty":-3.767089,"median":10.848066,"eighty":89.994993,"marketCap":194219964},{"date":"2020-08-21","current":-10.318249,"twenty":-3.830522,"median":10.768359,"eighty":89.994993,"marketCap":195119130},{"date":"2020-08-28","current":-10.451388,"twenty":-3.868036,"median":10.752318,"eighty":89.994993,"marketCap":197636796},{"date":"2020-09-04","current":-10.318249,"twenty":-4.055681,"median":10.728255,"eighty":89.994993,"marketCap":195119130},{"date":"2020-09-11","current":-9.933573,"twenty":-4.079554,"median":10.70419,"eighty":89.994993,"marketCap":187844873},{"date":"2020-09-18","current":-10.26119,"twenty":-4.112976,"median":10.680128,"eighty":89.994993,"marketCap":194040130},{"date":"2020-09-25","current":-9.519417,"twenty":-4.124571,"median":10.648043,"eighty":89.994993,"marketCap":180013133},{"date":"2020-10-02","current":-9.852264,"twenty":-4.151855,"median":10.619969,"eighty":89.994993,"marketCap":186307298},{"date":"2020-10-09","current":-10.090011,"twenty":-4.18937,"median":10.591895,"eighty":89.994993,"marketCap":190803131},{"date":"2020-10-16","current":-10.023442,"twenty":-4.220745,"median":10.563821,"eighty":89.994993,"marketCap":189544298},{"date":"2020-10-23","current":-9.918833,"twenty":-4.267127,"median":10.531737,"eighty":89.994993,"marketCap":187566131},{"date":"2020-10-30","current":-9.22461,"twenty":-4.276786,"median":10.503663,"eighty":89.994993,"marketCap":174438301},{"date":"2020-11-06","current":-9.937853,"twenty":-4.294411,"median":10.48361,"eighty":89.994993,"marketCap":187925798},{"date":"2020-11-13","current":-10.280209,"twenty":-4.304642,"median":10.451525,"eighty":89.994993,"marketCap":194399797},{"date":"2020-11-20","current":-10.527467,"twenty":-4.318284,"median":10.41543,"eighty":89.994993,"marketCap":199075463},{"date":"2020-11-27","current":-10.831784,"twenty":-4.331244,"median":10.367304,"eighty":89.994993,"marketCap":204830128},{"date":"2020-12-04","current":-11.25022,"twenty":-4.348296,"median":10.307145,"eighty":89.994993,"marketCap":212742793},{"date":"2020-12-11","current":-11.117081,"twenty":-4.366712,"median":10.267039,"eighty":89.994993,"marketCap":210225127},{"date":"2020-12-18","current":-11.449928,"twenty":-4.408319,"median":10.218913,"eighty":89.994993,"marketCap":216519293},{"date":"2020-12-24","current":-11.012472,"twenty":-4.478574,"median":10.178807,"eighty":89.994993,"marketCap":208246961},{"date":"2020-12-31","current":-11.079042,"twenty":-4.492898,"median":10.158755,"eighty":89.994993,"marketCap":209505794},{"date":"2021-01-08","current":-11.098061,"twenty":-4.537915,"median":10.102607,"eighty":89.994993,"marketCap":209865461},{"date":"2021-01-15","current":-11.26924,"twenty":-4.592892,"median":9.9863,"eighty":89.994993,"marketCap":213102460},{"date":"2021-01-22","current":-11.25973,"twenty":-4.634772,"median":9.882025,"eighty":89.994993,"marketCap":212922627},{"date":"2021-01-29","current":-9.384477,"twenty":-5.012694,"median":8.507985,"eighty":89.994993,"marketCap":209865461},{"date":"2021-02-05","current":-9.673973,"twenty":-5.126545,"median":8.507985,"eighty":89.994993,"marketCap":216339459},{"date":"2021-02-12","current":-9.875011,"twenty":-5.23389,"median":8.507985,"eighty":89.994993,"marketCap":220835292},{"date":"2021-02-19","current":-9.899136,"twenty":-5.250154,"median":8.507985,"eighty":89.994993,"marketCap":221374792},{"date":"2021-02-26","current":-9.794596,"twenty":-5.267249,"median":8.507985,"eighty":89.994993,"marketCap":219036959},{"date":"2021-03-05","current":-9.887121,"twenty":-5.287562,"median":8.507985,"eighty":90.097979,"marketCap":221106101},{"date":"2021-03-12","current":-10.256583,"twenty":-5.303827,"median":8.507985,"eighty":90.097979,"marketCap":229368393},{"date":"2021-03-19","current":-10.192329,"twenty":-5.324157,"median":8.507985,"eighty":90.097979,"marketCap":227931473},{"date":"2021-03-26","current":-10.06382,"twenty":-5.337169,"median":8.507985,"eighty":89.994993,"marketCap":225057632},{"date":"2021-04-01","current":-10.272646,"twenty":-5.356686,"median":8.507985,"eighty":89.994993,"marketCap":229727623},{"date":"2021-04-09","current":-10.505568,"twenty":-5.387589,"median":8.507985,"eighty":90.097979,"marketCap":234936459},{"date":"2021-04-16","current":-10.690299,"twenty":-5.391655,"median":8.507985,"eighty":90.097979,"marketCap":239067604},{"date":"2021-04-23","current":-10.674235,"twenty":-5.414425,"median":8.507985,"eighty":90.097979,"marketCap":238708374},{"date":"2021-04-30","current":-10.794712,"twenty":-5.459966,"median":8.507985,"eighty":90.097979,"marketCap":241402600},{"date":"2021-05-07","current":-10.931252,"twenty":-5.477043,"median":8.507985,"eighty":90.097979,"marketCap":244456055},{"date":"2021-05-14","current":-10.794712,"twenty":-5.499813,"median":8.507985,"eighty":90.097979,"marketCap":241402600},{"date":"2021-05-21","current":-11.027634,"twenty":-5.52177,"median":8.507985,"eighty":90.097979,"marketCap":246611436},{"date":"2021-05-28","current":-11.308746,"twenty":-5.539661,"median":8.507985,"eighty":90.097979,"marketCap":252897962},{"date":"2021-06-04","current":-11.549699,"twenty":-5.555112,"median":8.507985,"eighty":90.097979,"marketCap":258286413},{"date":"2021-06-11","current":-11.935225,"twenty":-5.57463,"median":8.507985,"eighty":90.097979,"marketCap":266907934},{"date":"2021-06-18","current":-11.493477,"twenty":-5.582762,"median":8.507985,"eighty":90.097979,"marketCap":257029107},{"date":"2021-06-25","current":-11.477413,"twenty":-5.590894,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-07-02","current":-11.738446,"twenty":-5.608785,"median":8.507985,"eighty":90.097979,"marketCap":262507366},{"date":"2021-07-09","current":-11.68624,"twenty":-5.619357,"median":8.507985,"eighty":90.097979,"marketCap":261339868},{"date":"2021-07-16","current":-11.405127,"twenty":-5.629115,"median":8.507985,"eighty":90.097979,"marketCap":255053342},{"date":"2021-07-23","current":-11.501509,"twenty":-5.673826,"median":8.507985,"eighty":90.097979,"marketCap":257208722},{"date":"2021-07-30","current":2.940516,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256131032},{"date":"2021-08-06","current":2.946703,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-08-13","current":2.992068,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":260621408},{"date":"2021-08-20","current":2.901337,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252718347},{"date":"2021-08-27","current":3.008565,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":262058328},{"date":"2021-09-03","current":3.045682,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":265291399},{"date":"2021-09-10","current":2.997966,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":261135107},{"date":"2021-09-17","current":2.946703,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-09-24","current":2.86422,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":249485276},{"date":"2021-10-01","current":2.855971,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":248766816},{"date":"2021-10-08","current":2.901337,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252718347},{"date":"2021-10-15","current":2.963199,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":258106798},{"date":"2021-10-22","current":3.035372,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264393324},{"date":"2021-10-29","current":3.039496,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264752554},{"date":"2021-11-05","current":3.066303,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":267087549},{"date":"2021-11-12","current":3.082799,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":268524469},{"date":"2021-11-19","current":3.041558,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264932169},{"date":"2021-11-26","current":2.98382,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":259902948},{"date":"2021-12-03","current":2.897213,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252359117},{"date":"2021-12-10","current":2.992068,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":260621408},{"date":"2021-12-17","current":2.981758,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":259723333},{"date":"2021-12-23","current":3.004441,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":261699098},{"date":"2021-12-31","current":3.134351,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":273014845},{"date":"2022-01-07","current":3.084862,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":268704084},{"date":"2022-01-14","current":3.047744,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":265471014},{"date":"2022-01-21","current":2.876592,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":250562966},{"date":"2022-01-28","current":2.907523,"twenty":-9.236022,"median":8.45586,"eighty":89.994993,"marketCap":253257192},{"date":"2022-02-04","current":3.014751,"twenty":-9.236022,"median":8.432693,"eighty":89.994993,"marketCap":262597173},{"date":"2022-02-11","current":2.942579,"twenty":-9.236022,"median":8.412422,"eighty":89.994993,"marketCap":256310647},{"date":"2022-02-18","current":2.921958,"twenty":-9.236022,"median":8.392152,"eighty":89.994993,"marketCap":254514497},{"date":"2022-02-25","current":2.913709,"twenty":-9.236022,"median":8.374777,"eighty":89.994993,"marketCap":253796037},{"date":"2022-03-04","current":2.882049,"twenty":-9.236022,"median":8.366089,"eighty":89.994993,"marketCap":251038288},{"date":"2022-03-11","current":2.817511,"twenty":-9.236022,"median":8.345818,"eighty":89.994993,"marketCap":245416717},{"date":"2022-03-18","current":2.914318,"twenty":-9.236022,"median":8.325547,"eighty":89.994993,"marketCap":253849074},{"date":"2022-03-25","current":2.884066,"twenty":-9.236022,"median":8.30238,"eighty":89.994993,"marketCap":251213963},{"date":"2022-04-01","current":2.972806,"twenty":-9.236022,"median":8.287901,"eighty":89.994993,"marketCap":258943623},{"date":"2022-04-08","current":2.884066,"twenty":-9.236022,"median":8.270526,"eighty":89.994993,"marketCap":251213963},{"date":"2022-04-14","current":2.851797,"twenty":-9.236022,"median":8.235776,"eighty":89.994993,"marketCap":248403177},{"date":"2022-04-22","current":2.851797,"twenty":-9.236022,"median":8.209598,"eighty":89.994993,"marketCap":248403177},{"date":"2022-04-29","current":2.682383,"twenty":-9.236022,"median":8.189443,"eighty":89.994993,"marketCap":233646553},{"date":"2022-05-06","current":2.734821,"twenty":-9.236022,"median":8.180755,"eighty":89.994993,"marketCap":238214079},{"date":"2022-05-13","current":2.625912,"twenty":-9.236022,"median":8.166276,"eighty":89.994993,"marketCap":228727678},{"date":"2022-05-20","current":2.60776,"twenty":-9.236022,"median":8.151797,"eighty":89.994993,"marketCap":227146611},{"date":"2022-05-27","current":2.797342,"twenty":-9.236022,"median":8.105463,"eighty":89.994993,"marketCap":243659976},{"date":"2022-06-03","current":2.823561,"twenty":-9.236022,"median":8.073609,"eighty":89.994993,"marketCap":245943740},{"date":"2022-06-10","current":2.732804,"twenty":-9.236022,"median":8.053338,"eighty":89.994993,"marketCap":238038405},{"date":"2022-06-17","current":2.404061,"twenty":-9.236022,"median":8.021484,"eighty":89.994993,"marketCap":209403527},{"date":"2022-06-24","current":2.500868,"twenty":-9.247434,"median":8.004109,"eighty":90.097979,"marketCap":217835884},{"date":"2022-07-01","current":2.517003,"twenty":-9.247434,"median":7.980942,"eighty":90.097979,"marketCap":219241276},{"date":"2022-07-08","current":2.537171,"twenty":-9.247434,"median":7.969359,"eighty":90.097979,"marketCap":220998017},{"date":"2022-07-15","current":2.535154,"twenty":-9.247434,"median":7.957775,"eighty":90.097979,"marketCap":220822343},{"date":"2022-07-22","current":2.595659,"twenty":-9.247434,"median":7.934609,"eighty":90.097979,"marketCap":226092566},{"date":"2022-07-29","current":2.704568,"twenty":-9.247434,"median":6.088551,"eighty":90.097979,"marketCap":235578968},{"date":"2022-08-05","current":2.688433,"twenty":-9.247434,"median":6.007831,"eighty":90.097979,"marketCap":234173575},{"date":"2022-08-12","current":2.785241,"twenty":-9.247434,"median":5.973237,"eighty":90.097979,"marketCap":242605932},{"date":"2022-08-19","current":2.785241,"twenty":-9.247434,"median":5.900205,"eighty":90.097979,"marketCap":242605932},{"date":"2022-08-26","current":2.696501,"twenty":-9.247434,"median":5.312107,"eighty":90.097979,"marketCap":234876271},{"date":"2022-09-02","current":2.573474,"twenty":-9.247434,"median":4.989229,"eighty":90.097979,"marketCap":224160151},{"date":"2022-09-09","current":2.654147,"twenty":-9.247434,"median":4.262754,"eighty":90.097979,"marketCap":231187115},{"date":"2022-09-16","current":2.573474,"twenty":-9.247434,"median":4.089784,"eighty":90.097979,"marketCap":224160151},{"date":"2022-09-23","current":2.31532,"twenty":-9.247434,"median":4.043659,"eighty":90.097979,"marketCap":201673866},{"date":"2022-09-30","current":2.272967,"twenty":-9.247434,"median":3.99369,"eighty":90.097979,"marketCap":197984710},{"date":"2022-10-07","current":2.291118,"twenty":-9.247434,"median":3.951408,"eighty":90.097979,"marketCap":199565777},{"date":"2022-10-14","current":2.268933,"twenty":-9.247434,"median":3.905283,"eighty":90.097979,"marketCap":197633362},{"date":"2022-10-21","current":2.333472,"twenty":-9.247434,"median":3.889907,"eighty":90.097979,"marketCap":203254933},{"date":"2022-10-28","current":2.450448,"twenty":-9.247434,"median":3.870689,"eighty":90.097979,"marketCap":213444031},{"date":"2022-11-04","current":2.429271,"twenty":-9.247434,"median":3.839938,"eighty":90.097979,"marketCap":211599453},{"date":"2022-11-11","current":2.581542,"twenty":-9.247434,"median":3.813032,"eighty":90.097979,"marketCap":224862848},{"date":"2022-11-18","current":2.559356,"twenty":-9.247434,"median":3.751531,"eighty":90.097979,"marketCap":222930432},{"date":"2022-11-25","current":2.597676,"twenty":-9.247434,"median":3.716937,"eighty":90.097979,"marketCap":226268240},{"date":"2022-12-02","current":2.585575,"twenty":-9.247434,"median":3.663124,"eighty":90.097979,"marketCap":225214196},{"date":"2022-12-09","current":2.4807,"twenty":-9.247434,"median":3.58671,"eighty":90.097979,"marketCap":216079143},{"date":"2022-12-16","current":2.460532,"twenty":-9.247434,"median":3.555498,"eighty":90.097979,"marketCap":214322402},{"date":"2022-12-23","current":2.381875,"twenty":-9.247434,"median":3.490154,"eighty":90.097979,"marketCap":207471112},{"date":"2022-12-30","current":2.428263,"twenty":-9.247434,"median":3.309496,"eighty":90.097979,"marketCap":211511616},{"date":"2023-01-06","current":2.420195,"twenty":-9.247434,"median":3.134351,"eighty":90.097979,"marketCap":210808920},{"date":"2023-01-13","current":2.537171,"twenty":-9.247434,"median":3.098088,"eighty":90.097979,"marketCap":220998017},{"date":"2023-01-20","current":2.484734,"twenty":-9.247434,"median":3.084862,"eighty":90.097979,"marketCap":216430491},{"date":"2023-01-27","current":2.535154,"twenty":-9.247434,"median":3.080737,"eighty":90.097979,"marketCap":220822343},{"date":"2023-02-03","current":-73.781452,"twenty":-9.441436,"median":3.070427,"eighty":90.097979,"marketCap":223633129},{"date":"2023-02-10","current":-73.607575,"twenty":-9.615782,"median":3.064241,"eighty":90.097979,"marketCap":223106107},{"date":"2023-02-17","current":-73.549616,"twenty":-9.666828,"median":3.055993,"eighty":90.097979,"marketCap":222930432},{"date":"2023-02-24","current":-71.289227,"twenty":-9.690595,"median":3.049806,"eighty":90.097979,"marketCap":216079143},{"date":"2023-03-03","current":-72.738194,"twenty":-9.745753,"median":3.04362,"eighty":90.097979,"marketCap":220470995},{"date":"2023-03-10","current":-69.376589,"twenty":-9.806616,"median":3.039496,"eighty":90.097979,"marketCap":210281897},{"date":"2023-03-17","current":-67.695786,"twenty":-9.852264,"median":3.025061,"eighty":90.097979,"marketCap":205187348},{"date":"2023-03-24","current":-66.826405,"twenty":-9.868605,"median":3.014751,"eighty":90.097979,"marketCap":202552237},{"date":"2023-03-31","current":-70.767598,"twenty":-9.889524,"median":3.009081,"eighty":89.994993,"marketCap":214498076},{"date":"2023-04-06","current":-69.666382,"twenty":-9.905569,"median":3.008565,"eighty":90.30395,"marketCap":211160268},{"date":"2023-04-19","current":-72.622277,"twenty":-9.923821,"median":3.000317,"eighty":90.612908,"marketCap":220119647},{"date":"2023-04-28","current":-70.477804,"twenty":-9.947385,"median":2.994306,"eighty":90.81888,"marketCap":213619705},{"date":"2023-05-05","current":-68.507208,"twenty":-9.985022,"median":2.990006,"eighty":90.81888,"marketCap":207646786},{"date":"2023-05-12","current":-69.724341,"twenty":-9.994912,"median":2.985882,"eighty":90.81888,"marketCap":211335942},{"date":"2023-05-19","current":-70.65168,"twenty":-10.046106,"median":2.981758,"eighty":90.81888,"marketCap":214146727},{"date":"2023-05-26","current":-69.492506,"twenty":-10.086379,"median":2.97351,"eighty":90.81888,"marketCap":210633245},{"date":"2023-06-02","current":-69.898217,"twenty":-10.114737,"median":2.967323,"eighty":90.81888,"marketCap":211862964},{"date":"2023-06-09","current":-71.984731,"twenty":-10.155699,"median":2.961137,"eighty":90.81888,"marketCap":218187232},{"date":"2023-06-16","current":-73.72813,"twenty":-10.198754,"median":2.952889,"eighty":90.81888,"marketCap":223471509},{"date":"2023-06-23","current":-72.04269,"twenty":-10.25168,"median":2.947653,"eighty":90.921866,"marketCap":218362906},{"date":"2023-06-30","current":-72.680236,"twenty":-10.270699,"median":2.944641,"eighty":90.951291,"marketCap":220295321},{"date":"2023-07-07","current":-71.694937,"twenty":-10.28097,"median":2.940516,"eighty":90.951291,"marketCap":217308861},{"date":"2023-07-14","current":-73.897369,"twenty":-10.318249,"median":2.932268,"eighty":90.951291,"marketCap":223984477},{"date":"2023-07-20","current":-74.882667,"twenty":-10.336901,"median":2.919896,"eighty":90.951291,"marketCap":226970937},{"date":"2023-07-28","current":-73.955328,"twenty":-10.373407,"median":2.915045,"eighty":90.097979,"marketCap":224160151},{"date":"2023-08-04","current":-21.900189,"twenty":-10.41739,"median":2.903399,"eighty":16.981542,"marketCap":223281781},{"date":"2023-08-11","current":-22.055265,"twenty":-10.473441,"median":2.901337,"eighty":16.844419,"marketCap":224862848},{"date":"2023-08-18","current":-22.072496,"twenty":-10.502916,"median":2.898184,"eighty":16.694236,"marketCap":225038522},{"date":"2023-08-25","current":-22.313725,"twenty":-10.566513,"median":2.891027,"eighty":16.544053,"marketCap":227497959},{"date":"2023-09-01","current":-22.882338,"twenty":-10.63247,"median":2.882837,"eighty":16.443931,"marketCap":233295204},{"date":"2023-09-08","current":-22.67557,"twenty":-10.683175,"median":2.880716,"eighty":16.319867,"marketCap":231187115},{"date":"2023-09-15","current":-22.244803,"twenty":-10.736884,"median":2.86422,"eighty":15.971617,"marketCap":226795263},{"date":"2023-09-22","current":-21.641729,"twenty":-10.809272,"median":2.8559,"eighty":15.823611,"marketCap":220646669},{"date":"2023-09-29","current":-21.15927,"twenty":-10.841294,"median":2.84978,"eighty":15.76702,"marketCap":215727794},{"date":"2023-10-06","current":-20.556197,"twenty":-10.858966,"median":2.844673,"eighty":15.730018,"marketCap":209579201},{"date":"2023-10-13","current":-21.176501,"twenty":-10.942973,"median":2.837413,"eighty":15.682134,"marketCap":215903468},{"date":"2023-10-20","current":-21.538345,"twenty":-11.00106,"median":2.831227,"eighty":15.636426,"marketCap":219592625},{"date":"2023-10-27","current":-19.901431,"twenty":-11.016276,"median":2.825578,"eighty":15.595072,"marketCap":202903585},{"date":"2023-11-03","current":-21.004194,"twenty":-11.082846,"median":2.817511,"eighty":15.534128,"marketCap":214146727},{"date":"2023-11-10","current":-20.590658,"twenty":-11.117081,"median":2.795325,"eighty":15.431829,"marketCap":209930549},{"date":"2023-11-17","current":-21.831267,"twenty":-11.164174,"median":2.785241,"eighty":15.34912,"marketCap":222579084},{"date":"2023-11-24","current":-22.244803,"twenty":-11.204054,"median":2.762048,"eighty":15.281647,"marketCap":226795263},{"date":"2023-12-01","current":-22.67557,"twenty":-11.254024,"median":2.732804,"eighty":15.148876,"marketCap":231187115},{"date":"2023-12-08","current":-22.589416,"twenty":-11.310355,"median":2.726754,"eighty":15.090109,"marketCap":230308745},{"date":"2023-12-15","current":-23.347566,"twenty":-11.356937,"median":2.704568,"eighty":15.022635,"marketCap":238038405},{"date":"2023-12-22","current":-23.881717,"twenty":-11.397096,"median":2.696501,"eighty":14.979104,"marketCap":243484302},{"date":"2023-12-29","current":-24.191869,"twenty":-11.411888,"median":2.69045,"eighty":14.913807,"marketCap":246646436},{"date":"2024-01-05","current":-23.881717,"twenty":-11.451962,"median":2.683391,"eighty":14.85504,"marketCap":243484302},{"date":"2024-01-12","current":-23.674949,"twenty":-11.477413,"median":2.65919,"eighty":14.800626,"marketCap":241376213},{"date":"2024-01-19","current":-23.45095,"twenty":-11.499903,"median":2.642046,"eighty":14.713563,"marketCap":239092450},{"date":"2024-01-26","current":-23.778333,"twenty":-11.543274,"median":2.622886,"eighty":14.58297,"marketCap":242430258},{"date":"2024-02-02","current":9.626529,"twenty":-11.568976,"median":2.616836,"eighty":14.349599,"marketCap":243659976},{"date":"2024-02-09","current":9.869448,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":249808570},{"date":"2024-02-16","current":9.834745,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":248930199},{"date":"2024-02-23","current":9.869448,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":249808570},{"date":"2024-03-01","current":9.786162,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":247700481},{"date":"2024-03-08","current":9.756733,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":246955611},{"date":"2024-03-15","current":10.007253,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":253296595},{"date":"2024-03-22","current":10.183294,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":257752421},{"date":"2024-03-28","current":10.460897,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":264778917},{"date":"2024-04-05","current":10.257773,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":259637579},{"date":"2024-04-12","current":10.176523,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":257581043},{"date":"2024-04-19","current":9.763504,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":247126989},{"date":"2024-04-26","current":10.14944,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":256895532},{"date":"2024-05-03","current":10.227304,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":258866378},{"date":"2024-05-10","current":10.413502,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":263579271},{"date":"2024-05-17","current":10.447356,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":264436161},{"date":"2024-05-24","current":10.217148,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":258609311},{"date":"2024-05-31","current":10.095274,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":255524508},{"date":"2024-06-07","current":10.406731,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":263407893},{"date":"2024-06-14","current":10.460897,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":264778917},{"date":"2024-06-21","current":10.359335,"twenty":-11.575401,"median":2.613811,"eighty":9.637634,"marketCap":262208248},{"date":"2024-06-28","current":10.403684,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":263330773},{"date":"2024-07-05","current":10.521834,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":266321318},{"date":"2024-07-12","current":10.494751,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":265635807},{"date":"2024-07-15","current":10.521834,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":266321318},{"date":"2024-08-02","current":4.208455,"twenty":-11.59789,"median":2.60171,"eighty":5.980925,"marketCap":267178208},{"date":"2024-08-09","current":4.170663,"twenty":-11.59789,"median":2.60171,"eighty":5.938643,"marketCap":264778917},{"date":"2024-08-16","current":4.265144,"twenty":-11.59789,"median":2.60171,"eighty":5.362076,"marketCap":270777145},{"date":"2024-08-23","current":4.421713,"twenty":-11.59789,"median":2.60171,"eighty":5.046886,"marketCap":280717065},{"date":"2024-08-30","current":4.421713,"twenty":-11.59789,"median":2.60171,"eighty":4.421713,"marketCap":280717065},{"date":"2024-09-06","current":4.419013,"twenty":-11.59789,"median":2.60171,"eighty":4.408215,"marketCap":280545687},{"date":"2024-09-13","current":4.451407,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":282602223},{"date":"2024-09-20","current":4.753746,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":301796552},{"date":"2024-09-27","current":4.699757,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":298368993},{"date":"2024-10-04","current":4.815833,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":305738244},{"date":"2024-10-11","current":4.664664,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":296141080},{"date":"2024-10-18","current":4.688959,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":297683481},{"date":"2024-10-25","current":4.591778,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":291513875},{"date":"2024-10-31","current":4.53509,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":287914939},{"date":"2024-11-08","current":4.613374,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292884899},{"date":"2024-11-15","current":4.599877,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292028009},{"date":"2024-11-22","current":4.670063,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":296483836},{"date":"2024-11-29","current":4.813134,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":305566867},{"date":"2024-12-06","current":4.756445,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":301967930},{"date":"2024-12-13","current":4.678161,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":296997970},{"date":"2024-12-20","current":4.443308,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":282088089},{"date":"2024-12-27","current":4.645768,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":294941434},{"date":"2025-01-03","current":4.605276,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292370765},{"date":"2025-01-10","current":4.526991,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":287400805},{"date":"2025-01-17","current":4.605276,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":292370765},{"date":"2025-01-24","current":4.769943,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":302824819},{"date":"2025-01-31","current":3.372162,"twenty":-11.610741,"median":2.597676,"eighty":4.349907,"marketCap":294084545},{"date":"2025-02-07","current":3.368232,"twenty":-11.610741,"median":2.597676,"eighty":4.270338,"marketCap":293741789},{"date":"2025-02-14","current":3.374127,"twenty":-11.610741,"median":2.597676,"eighty":4.219659,"marketCap":294255922},{"date":"2025-02-21","current":3.415395,"twenty":-11.610741,"median":2.597676,"eighty":4.178221,"marketCap":297854859},{"date":"2025-02-28","current":3.295129,"twenty":-11.610741,"median":2.597676,"eighty":4.101017,"marketCap":287366529},{"date":"2025-03-07","current":3.155998,"twenty":-11.617166,"median":2.597676,"eighty":4.050578,"marketCap":275232971},{"date":"2025-03-14","current":3.072474,"twenty":-11.617166,"median":2.597676,"eighty":4.019762,"marketCap":267948919},{"date":"2025-03-21","current":3.19042,"twenty":-11.617166,"median":2.602718,"eighty":4.019762,"marketCap":278234866},{"date":"2025-03-28","current":3.143241,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":274120487},{"date":"2025-04-04","current":3.008068,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":262332100},{"date":"2025-04-11","current":2.734909,"twenty":-11.610741,"median":2.605743,"eighty":4.017423,"marketCap":238510000},{"date":"2025-04-17","current":2.844071,"twenty":-11.610741,"median":2.605743,"eighty":4.017423,"marketCap":248030000},{"date":"2025-04-25","current":2.941538,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":256530000},{"date":"2025-05-02","current":2.982474,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":260100000},{"date":"2025-05-09","current":2.966879,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":258740000},{"date":"2025-05-16","current":3.07994,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":268600000},{"date":"2025-05-23","current":3.048751,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":265880000},{"date":"2025-05-30","current":3.081889,"twenty":-11.617166,"median":2.604735,"eighty":4.005123,"marketCap":268770000},{"date":"2025-06-06","current":3.280721,"twenty":-11.617166,"median":2.604735,"eighty":3.951408,"marketCap":286110000},{"date":"2025-06-13","current":3.035105,"twenty":-11.617166,"median":2.604735,"eighty":3.905283,"marketCap":264690000},{"date":"2025-06-20","current":3.084001,"twenty":-11.623592,"median":2.603727,"eighty":3.88837,"marketCap":268954204},{"date":"2025-06-27","current":3.062339,"twenty":-11.623592,"median":2.603727,"eighty":3.873763,"marketCap":267064998},{"date":"2025-07-03","current":3.145051,"twenty":-11.623592,"median":2.603727,"eighty":3.866076,"marketCap":274278330},{"date":"2025-07-07","current":3.145051,"twenty":-11.623592,"median":2.603727,"eighty":3.846088,"marketCap":274278330}],"updateTime":1752015178981}}}